Streptomyces tauricus (Ivanitskaya et al.) Pridham
商品貨號
B169301
Strain Designations
ISP 5560 [CBS 757.72, IFO 13456, INA 8173, RIA 1417]
Application
Produces MS-282a
Produces MS-282b
Produces myosin light chain kinase inhibitors MS-282a and MS-282b
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Preceptrol®
no
Type Strain
yes
(type strain)
Medium
ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor
EB Shirling
Chain of Custody
ATCC <<--EB Shirling<<--G. Gauze INA 8173
References
Nakanishi S, et al. MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470. J. Antibiot. 47: 855-861, 1994. PubMed: 7928670
Shirling EB, Gottlieb D. Cooperative description of type strains of Streptomyces. V. Additional descriptions. Int J Syst Bacteriol 22: 265-394, 1972.
Validation list no. 22. Int. J. Syst. Bacteriol. 36: 573-576, 1986.
